OrbiMed, a global investment management firm focused on the healthcare sector, announced the launch of a $222 million investment fund dedicated to life sciences venture capital opportunities based in Israel. The fund, OrbiMed Israel Partners Limited Partnership, includes an anchor investment provided by the Government of Israel. According to OrbiMed, the fund is led by three Israel-based partners – Dr. Nissim Darvish, Anat Naschitz and Erez Chimovits.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments